MarginsXMarginsX
Home › Markets › Health Care › ADGM

Adagio Medical Holdings Inc (ADGM)

ADGM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.61
-16.58% on the day
Market cap
$44.2M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$25.1M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/2006986/000200698626000003/0002006986-26-000003-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerADGM on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0002006986
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$25.1M
Operating income-$21.9M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$17.1M
Total assets$43.3M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
5.6 months
$7.7M cash at June 30, 2026
Share count, 1 year
+44.4%
2025-08-11 to 2026-08-10
Going-concern doubt
Yes
10-Q filed August 11, 2026
Insider net buying, 12 months
$244K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Management intends to mitigate the conditions and events that raise substantial doubt about the Company's ability to continue as a going concern entity by (i) negotiating other cash equity, debt or strategic financing in the short-term, (ii) continuing to pursue the necessary regulatory approvals to launch commercially in the U.S. market, and (iii) executing cost-cutting measures to manage cash burn."
10-Q 2026-08-11
Cash and burn$7.7M cash; operating cash flow -$4.1M a quarter.Report 2026-06-30
Shares outstandingNo cover-page share count in XBRLCover page 2026-08-10
Reverse splits, 3 years1; latest 1-for-30 on 2026-11-09Source 2026-11-09
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2025-11-24
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-08-14
AuditorWithumSmith+Brown, PC, Whippany, New Jersey, United StatesPCAOB Form AP 2026-03-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $244K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$0-$6.7M-$5.3M$7.7M$24.8M$010-Q 2026-08-11
Q1 2026
2026-03-31
$0-$7.0M-$4.1M$12.9M$22.9M$010-Q 2026-05-12
Q4 2025
2025-12-31
$0-$3.3M-$4.1M$17.1M$21.0M$010-K 2026-03-27
Q3 2025
2025-09-30
$0-$10.1M-$3.0M$4.7M$21.2MNeeds four quarters10-Q 2025-11-12
Q2 2025
2025-06-30
$0-$3.9M-$4.7M$8.2M$16.9MNeeds four quarters10-Q 2026-08-11
Q1 2025
2025-03-31
$0-$7.7M-$7.2M$13.0M$17.7MNeeds four quarters10-Q 2026-05-12
Q3 2024
2024-09-30
Not filed-$8.2MNot filed$28.3M$13.8MNeeds four quarters10-Q 2025-11-12
Q2 2024
2024-06-30
$254K-$5.7M-$6.9M$2.0MNo debt tags$399K10-Q 2025-08-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2026-04-02
Latest annual report
FORM 10-K/A
10-K/A2026-07-13
Latest quarterly / interim10-Q2026-08-11
Latest current report8-K2026-11-16
Latest proxyPRE 14A2026-11-10

Source: SEC EDGAR submissions feed, 236 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.0%
1 month-48.5%
3 months-90.7%
Year to date-93.8%
1 year-92.1%
From 52-week high-96.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
MBOTMicrobot Medical Inc.$0.6444-34.16%$43.3M
MDAISpectral AI Inc.$1.31+0.77%$42.2M
DXRDaxor Corporation$8.36-0.89%$48.8M
SRTSSensus Healthcare Inc.$2.34+0.65%$38.5M
TELATELA Bio Inc.$0.7616-7.13%$34.4M
NEPHNephros Inc.$3.00-1.64%$32.6M
QTEXQTREX Quantum Ltd.$1.15-8.00%$64.4M
LNSRLENSAR Inc.$5.29+5.80%$65.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier